LYZ and Alzheimer disease: By contrast, in AD patients a significantly increased level of serum antibodies to both prefibrillar amyloids of Aβ and human lysozyme was found in the early stage of disease [8] and biphasic antibody levels to Aβ peptide oligomers - during the progression of dementia [7].